| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Baofu Zheng CEO | SSE Exchange | CNE1000051J4 ISIN |
| CN Country | 3,370 Employees | 22 Oct 2025 Last Dividend | 27 Jun 2024 Last Split | - IPO Date |
Shanghai Haoyuan Chemexpress Co., Ltd. is a prominent player in the pharmaceutical industry, dedicated to the research, development, and manufacture of pharmaceutical intermediates and small molecule drugs. Established in 2006, the company has carved out a significant niche for itself in the competitive landscape of the pharmaceutical sector. Headquartered in Shanghai, China, it has earned a reputation for its excellence in producing high-quality Active Pharmaceutical Ingredients (APIs) and API intermediates. By focusing on innovation and precision, Shanghai Haoyuan Chemexpress has become an integral partner for pharmaceutical companies across the globe, enabling them to develop and produce effective, reliable pharmaceutical products.